top of page
Search

24th ASBrS Annual Meeting


We are happy to announce that our team got accepted four abstracts to be presented at the ASBrS Annual Meeting 2023.

  1. Role of Axillary Lymph Node Dissection for Isolated Tumor Cells Following Neoadjuvant Chemotherapy (Estefania Roldan, MD)

  2. ECHS1 Mediates Metabolic Disruption in Hormone Receptor-positive Breast Tumor Microenvironment (Tina Bharani, MD)

  3. Feasibility of Deescalating Axillary Surgery in cN2 patients after Neoadjuvant Chemotherapy (Kathryn Capasso, MD)

  4. Impact of Delayed Sentinel Lymph Node Biopsy: A Single Institution Experience (Kathryn Capasso, MD)



 
 
 

Comments


MEDICAL DISCLAIMER

All content found on this website, including text, images, audio, or other formats were created for informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare professional for any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

BREAST CANCER SURGERY OUTCOMES RESEARCH PROGRAM 

BCRC Lab Logo.png

Deaconess, FIRST Program, Office 207

Boston, MA 02215

Mail: breastcancersorp@gmail.com

Tel: 617-632-7023

SOCIALS

  • Facebook
  • Twitter
bottom of page